NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-185-1994-0-SE-17 SERIALLY PASSAGED AFRICAN GREEN MONKEY KIDNEY CELLS SE EP 95941434.3 Expired
NIAID E-185-1994-0-CH-21 SERIALLY PASSAGED AFRICAN GREEN MONKEY KIDNEY CELLS CH EP 95941434.3 Expired
NIAID E-185-1994-0-GR-03 SERIALLY PASSAGED AFRICAN GREEN MONKEY KIDNEY CELLS GR EP 95941434.3 Expired
NIAID E-185-1994-0-IT-13 SERIALLY PASSAGED AFRICAN GREEN MONKEY KIDNEY CELLS IT EP 95941434.3 Expired
NIAID E-185-1994-0-EP-04 SERIALLY PASSAGED AFRICAN GREEN MONKEY KIDNEY CELLS EP National Stage 95941434.3 Expired
NCI E-008-1996-0-US-01 C-C CHEMOKINES THAT INHIBIT RETROVIRUS INFECTION US 60/007,817 Abandoned
NIAID E-185-1994-0-CA-07 SERIALLY PASSAGED AFRICAN GREEN MONKEY KIDNEY CELLS WHICH ARE A SUBSTRATE FOR GROWTH OF VIRUSES AND PREPARATION OF VIRAL VACCINES CA National Stage 2201585 Abandoned
NCI E-034-1996-0-US-01 METHODS FOR THE DIAGNOSIS OF A GENETIC PREDISPOSITION TO CANCER ASSOCIATED WITH VARIANT CDK4 GENE US ORD 08/564,002 5714329 Abandoned PDF
NCI E-212-1994-1-PCT-01 TISSUE-SPECIFIC TREATMENT, DIAGNOSTIC METHODS, AND COMPOSITIONS USING REPLICATION-DEFICIENT VECTORS PCT PCT COMB PCT/US1995/015431 Expired
NCI E-212-1994-1-EP-02 TISSUE-SPECIFIC TREATMENT, DIAGNOSTIC METHODS, AND COMPOSITIONS USING REPLICATION-DEFICIENT VECTORS EP National Stage 95943609.8 Abandoned
NCI E-029-1996-0-US-01 NOVEL RETROVIRAL AGENTS CONTAINING ANTHRANILAMIDE, SUBSTITUTED BENZAMIDE AND OTHER SUBUNITS, AND METHODS OF USING SAME US ORD 08/562,013 5763464 Expired PDF
NCI E-196-1992-3-CA-04 BIOPOLYMER-BOUND NITRIC OXIDE/NUCLEOPHILE ADDUCT COMPOSITIONS, PHARMACEUTICAL COMPOSITIONS INCORPORATING SAME AND METHODS OF.... CA National Stage 2205564 Abandoned
NCI E-196-1992-3-DE-11 PHARMACEUTICAL COMPOSITIONS COMPRISING NITRIC OXIDE-RELEASING POLYSACCHARIDES DE EP 95941444.2 Abandoned
NCI E-196-1992-3-FR-12 PHARMACEUTICAL COMPOSITIONS COMPRISING NITRIC OXIDE-RELEASING POLYSACCHARIDES FR EP 95941444.2 Abandoned
NCI E-196-1992-3-IE-13 PHARMACEUTICAL COMPOSITIONS COMPRISING NITRIC OXIDE-RELEASING POLYSACCHARIDES IE EP 95941444.2 Abandoned
NCI E-196-1992-3-IT-14 PHARMACEUTICAL COMPOSITIONS COMPRISING NITRIC OXIDE-RELEASING POLYSACCHARIDES IT EP 95941444.2 Abandoned
NCI E-196-1992-3-GB-10 PHARMACEUTICAL COMPOSITIONS COMPRISING NITRIC OXIDE-RELEASING POLYSACCHARIDES GB EP 95941444.2 Abandoned
NCI E-196-1992-3-CH-15 PHARMACEUTICAL COMPOSITIONS COMPRISING NITRIC OXIDE-RELEASING POLYSACCHARIDES CH EP 95941444.2 Abandoned
NCI E-196-1992-3-BE-16 PHARMACEUTICAL COMPOSITIONS COMPRISING NITRIC OXIDE-RELEASING POLYSACCHARIDES BE EP 95941444.2 Abandoned
NCI E-196-1992-3-EP-05 PHARMACEUTICAL COMPOSITIONS COMPRISING NITRIC OXIDE-RELEASING POLYSACCHARIDES EP National Stage 95941444.2 Abandoned
NCI E-196-1992-3-JP-06 BIOPOLYMER-BOUND NITRIC OXIDE/NUCLEOPHILE ADDUCT COMPOSITIONS, PHARMACEUTICAL COMPOSITIONS INCORPORATING SAME AND METHODS OF.... JP National Stage 1996-517048 Abandoned
NCI E-020-1995-0-AU-05 USE OF NITRIC OXIDE-RELEASING AGENTS FOR REDUCING METASTASIS RISK AU National Stage 42460/96 Abandoned
NCI E-196-1992-3-PCT-02 PHARMACEUTICAL COMPOSITIONS COMPRISING NITRIC OXIDE-RELEASING BIOPOLYMERS PCT PCT PCT/US1995/015180 Expired
NCI E-020-1995-0-PCT-02 USE OF NITRIC OXIDE-RELEASING AGENTS FOR REDUCING METASTASIS RISK PCT PCT PCT/US1995/015381 Abandoned
NCI E-020-1995-0-JP-04 USE OF NITRIC OXIDE-RELEASING AGENTS FOR REDUCING METASTASIS RISK JP National Stage 1996-517097 Abandoned
NCI E-196-1992-3-EP-09 PHARMACEUTICAL COMPOSITIONS COMPRISING NITRIC OXIDE-RELEASING BIOPLOYMERS EP DIV 06002227.4 Abandoned
NCI E-020-1995-0-EP-03 USE OF NITRIC OXIDE-RELEASING AGENTS FOR REDUCING METASTASIS RISK EP National Stage 95940844.4 Abandoned
NCI E-196-1992-3-AU-03 BIOPOLYMER-BOUND NITRIC OXIDE/NUCLEOPHILE ADDUCT COMPOSITIONS, PHARMACEUTICAL COMPOSITIONS INCORPORATING SAME AND METHODS OF.... AU National Stage 42864/96 Abandoned
NCI E-185-1995-0-US-01 INHIBITORY AND NON-INHIBITORY ANTIGEN BINDING POLYPEPTIDES AGAINST HUMAN P450 ENZYMES US ORD 08/559,808 5939530 Expired PDF
NHLBI E-225-1994-0-CA-03 LIPID VESICLES CONTAINING ADENO-ASSOCIATED VIRUS REP PROTEIN FOR TRANSGENE INTEGRATION AND GENE THERAPY CA National Stage 2205874 Abandoned
NIDDK E-138-1992-1-GB-20 METHOD OF IDENTIFYING CFTR-BINDING COMPOUNDS USEFUL FOR ACTIVATING CHLORIDE CONDUCTANCE IN ANIMAL CELLS GB EP 95939767.0 Abandoned
NHLBI E-225-1994-0-PCT-02 LIPID VESICLES CONTAINING ADENO-ASSOCIATED VIRUS REP PROTEIN FOR TRANSGENE INTEGRATION AND GENE THERAPY PCT PCT PCT/US1995/013190 Expired
NEI E-173-1994-0-PCT-02 METHODS FOR INHIBITING CELL PROLIFERATION BY INHIBITING THE MITOGENIC ACTIVITY OF MACROPHAGE MIGRATION INHIBITORY FACTOR PCT PCT PCT/US1995/015000 Expired
NHLBI E-225-1994-0-JP-05 LIPID VESICLES CONTAINING ADENO-ASSOCIATED VIRUS REP PROTEIN FOR TRANSGENE INTEGRATION AND GENE THERAPY JP National Stage 1996-516836 Abandoned
NHLBI E-225-1994-0-EP-04 LIPID VESICLES CONTAINING ADENO-ASSOCIATED VIRUS REP PROTEIN FOR TRANSGENE INTEGRATION AND GENE THERAPY EP National Stage 95943565.2 Abandoned
NCI E-155-1992-0-US-06 METHOD OF INHIBITING VIRAL REPLICATION US DIV 08/558,384 Abandoned
NHLBI E-007-1996-0-US-01 USE OF LECITHIN-CHOLESTEROL ACYLTRANSFERASE (LCAT) IN THE TREATMENT OF ATHEROSCLEROSIS US 60/006,400 Abandoned
NIAAA E-014-1996-0-US-01 ALLELIC VARIATION OF THE SEROTONIN 5HT7 RECEPTOR US 60/006,394 Abandoned
NIDDK E-138-1992-1-JP-06 METHOD OF IDENTIFYING CFTR-BINDING COMPOUNDS USEFUL FOR ACTIVATING CHLORIDE CONDUCTANCE IN ANIMAL CELLS JP DIV 2002-127701 Abandoned
NIDDK E-138-1992-1-DE-17 METHOD OF IDENTIFYING CFTR-BINDING COMPOUNDS USEFUL FOR ACTIVATING CHLORIDE CONDUCTANCE IN ANIMAL CELLS DE EP 95939767.0 Abandoned
NIDDK E-138-1992-1-FR-19 METHOD OF IDENTIFYING CFTR-BINDING COMPOUNDS USEFUL FOR ACTIVATING CHLORIDE CONDUCTANCE IN ANIMAL CELLS FR EP 95939767.0 Abandoned
NIDDK E-138-1992-1-CH-16 METHOD OF IDENTIFYING CFTR-BINDING COMPOUNDS USEFUL FOR ACTIVATING CHLORIDE CONDUCTANCE IN ANIMAL CELLS CH EP 95939767.0 Abandoned
NIDDK E-138-1992-1-BE-15 METHOD OF IDENTIFYING CFTR-BINDING COMPOUNDS USEFUL FOR ACTIVATING CHLORIDE CONDUCTANCE IN ANIMAL CELLS BE EP 95939767.0 Abandoned
NIDDK E-138-1992-1-ES-18 METHOD OF IDENTIFYING CFTR-BINDING COMPOUNDS USEFUL FOR ACTIVATING CHLORIDE CONDUCTANCE IN ANIMAL CELLS ES EP 95939767.0 Abandoned
NIDDK E-138-1992-1-IE-21 METHOD OF IDENTIFYING CFTR-BINDING COMPOUNDS USEFUL FOR ACTIVATING CHLORIDE CONDUCTANCE IN ANIMAL CELLS IE EP 95939767.0 Abandoned
NIDDK E-138-1992-1-EP-12 Xanthines For Identifying CFTR-Binding Compounds Useful For Activating Chloride Conductance IN Animal Cells EP National Stage 95939767.0 Abandoned
NIDDK E-138-1992-1-JP-13 METHOD OF IDENTIFYING CFTR-BINDING COMPOUNDS USEFUL FOR ACTIVATING CHLORIDE CONDUCTANCE IN ANIMAL CELLS JP National Stage 1996-516905 Abandoned
NIDDK E-138-1992-1-CN-11 Xanthines For Identifying CFTR-Binding Compounds Useful For Activating Chloride Conductance IN Animal Cells CN National Stage 95197439.4 Abandoned
NIDDK E-138-1992-1-KR-07 METHOD OF IDENTIFYING CFTR-BINDING COMPOUNDS USEFUL FOR ACTIVATING CHLORIDE CONDUCTANCE IN ANIMAL CELLS KR National Stage 10-1997-0703454 Abandoned
NIDDK E-138-1992-1-SG-08 METHOD OF IDENTIFYING CFTR-BINDING COMPOUNDS USEFUL FOR ACTIVATING CHLORIDE CONDUCTANCE IN ANIMAL CELLS SG National Stage 9704706-2 Abandoned